Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis.

scientific article published on May 1996

Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.40.5.1104
P932PMC publication ID163273
P698PubMed publication ID8723448

P2093author name stringMalmborg AS
Karlsson M
Wretlind B
Nilsson-Ehle I
Hammers S
P2860cites workTreatment of the Early Manifestations of Lyme DiseaseQ22241125
New Chemotherapeutic Approaches in the Treatment of Lyme BorreliosisQ22242308
Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in miceQ33754842
Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosisQ34330551
Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosisQ34613449
Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agentsQ35281053
In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agentsQ35536241
Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosisQ35566456
Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilisQ35646489
Susceptibility of the Lyme disease spirochete to seven antimicrobial agents.Q36989113
Detection of Borrelia burgdorferi DNA in urine samples and cerebrospinal fluid samples from patients with early and late Lyme neuroborreliosis by polymerase chain reactionQ37122905
Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosisQ37227753
Antibiotic treatment in Lyme borreliosisQ37499658
Treatment of Lyme borreliosis with emphasis on neurological diseaseQ39540057
Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migransQ43970732
Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children--a prospective studyQ44300217
Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a follow-up study of 72 patients over 27 yearsQ44700572
Neurosyphilis and penicillin levels in cerebrospinal fluidQ45205280
The use of doxycycline in nervous system Borrelia burgdorferi infection.Q45273492
Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized studyQ47581031
Doxycycline carrageenate--an improved formulation providing more reliable absorption and plasma concentrations at high gastric pH than doxycycline monohydrate.Q51597518
Clinical and microbiologic findings in six patients with erythema migrans of Lyme disease.Q54340410
Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migransQ58402734
The Spirochetal Etiology of Lyme DiseaseQ58402764
Clinical manifestations and diagnosis of neuroborreliosisQ67966890
European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibilityQ69007212
Penicillin concentrations in serum and CSF during high-dose intravenous treatment for neurosyphilisQ69080706
Evaluation of a micromethod for determination of antibiotic concentrations in plasmaQ69242341
Doxycycline blood levels in normal subjects after intravenous and oral administrationQ69379655
In vitro and in vivo susceptibility of Borrelia burgdorferiQ69421586
Treatment of Lyme borreliosis. Randomized comparison of doxycycline and penicillin GQ69429410
Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillinQ70178390
Single versus multiple dose doxycycline prophylaxis in elective colorectal surgeryQ70371884
Serum and Cerebrospinal Fluid Concentrations of a New Tetracycline, DoxycyclineQ72426389
Penicillin concentrations in cerebrospinal fluid and serum after intramuscular, intravenous, and oral administration to syphilitic patientsQ72703858
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectcerebrospinal fluidQ54196
Lyme diseaseQ201989
benzylpenicillinQ258450
doxycyclineQ422442
P304page(s)1104-1107
P577publication date1996-05-01
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleConcentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis
P478volume40

Reverse relations

cites work (P2860)
Q90028021An unexpectedly high occurrence of aciclovir-induced neuropsychiatric symptoms in patients treated for herpesvirus CNS infection: a prospective observational study
Q33977417Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents
Q36679488Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know
Q37072897Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie
Q53688834Bacteremia and meningitis caused by OXA-23-producing Acinetobacter baumannii - molecular characterization and susceptibility testing for alternative antibiotics.
Q42163224Blocking human fear memory with the matrix metalloproteinase inhibitor doxycycline
Q38100704Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.
Q91803575Combining Ceftriaxone with Doxycycline and Daptomycin Reduces Mortality, Neuroinflammation, Brain Damage, and Hearing Loss in Infant Rat Pneumococcal Meningitis
Q79770430Diagnosis and treatment of the neuromuscular manifestations of lyme disease
Q34372745Doxycycline-mediated effects on persistent symptoms and systemic cytokine responses post-neuroborreliosis: a randomized, prospective, cross-over study
Q40303844Hypoxia-activated microglial mediators of neuronal survival are differentially regulated by tetracyclines
Q36020841Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline
Q60937233Looking at the positives: proactive management of STIs in people with HIV
Q73762957Lyme borreliosis
Q35207029Lyme meningo-radiculitis responsive to oral doxycycline therapy in the USA.
Q46529042Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial
Q35990112Orientia, rickettsia, and leptospira pathogens as causes of CNS infections in Laos: a prospective study
Q34142328Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections
Q36083619Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.
Q47135235Practical considerations for choosing a mouse model of Alzheimer's disease
Q33436124Severe human monocytic ehrlichiosis presenting with altered mental status and seizures
Q37683108Spirochetal infections
Q34761872Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents--possible implications for new therapeutic approaches to Lyme disease.
Q46110072Tet system in the brain: transgenic rats and lentiviral vectors approach.
Q38842593Tet-On Systems For Doxycycline-inducible Gene Expression.
Q90729704Threat Memory Reminder Under Matrix Metalloproteinase 9 Inhibitor Doxycycline Globally Reduces Subsequent Memory Plasticity

Search more.